Logo

CTA-PB

E. I. du Pont de Nemours and Company

CTA-PB

E. I. du Pont de Nemours and Company • NYSE
$67.41 ▼ -0.91% (-0.62)
Market Cap $58.50 B
52w High $74.63
52w Low $66.65
Dividend Yield 4.50%
P/E 0
Volume 3.46K
Outstanding Shares 867.81M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $2.618B ▼ $1.282B ▼ $-320M ▼ -12.223% ▼ $-0.47 ▼ $-24M ▼
Q2-2025 $6.456B ▲ $1.692B ▲ $1.314B ▲ 20.353% ▲ $1.93 ▲ $2.157B ▲
Q1-2025 $4.417B ▲ $1.248B ▲ $652M ▲ 14.761% ▲ $0.95 ▲ $1.116B ▲
Q4-2024 $3.978B ▲ $1.155B ▼ $-41M ▲ -1.031% ▲ $-0.06 ▲ $450M ▲
Q3-2024 $2.326B $1.226B $-524M -22.528% $-0.76 $-261M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $2.586B ▲ $42.198B ▲ $16.737B ▲ $25.219B ▼
Q2-2025 $2.141B ▲ $41.759B ▼ $15.608B ▼ $25.909B ▲
Q1-2025 $2.009B ▼ $42.123B ▲ $17.596B ▲ $24.285B ▲
Q4-2024 $3.169B ▲ $40.825B ▼ $16.795B ▼ $23.789B ▼
Q3-2024 $2.493B $41.908B $16.929B $24.737B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-395M ▼ $193M ▼ $-157M ▲ $367M ▲ $420M ▲ $36M ▼
Q2-2025 $1.382B ▲ $947M ▲ $-164M ▼ $-808M ▼ $22M ▲ $829M ▲
Q1-2025 $667M ▲ $-2.109B ▼ $-34M ▲ $995M ▲ $-1.127B ▼ $-2.203B ▼
Q4-2024 $-52M ▲ $4.173B ▲ $-123M ▲ $-3.336B ▼ $666M ▲ $3.992B ▲
Q3-2024 $-522M $130M $-161M $619M $615M $-24M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Crop Protection
Crop Protection
 $2.86Bn ▲$860.00M ▼$990.00M ▲$810.00M ▼
Seed
Seed
 $6.18Bn ▲$2.07Bn ▼$2.96Bn ▲$590.00M ▼

Five-Year Company Overview

Income Statement

Income Statement Revenue has generally trended upward over the past few years, though it has eased slightly from its recent peak, which is typical for a company exposed to industrial and agricultural cycles. Profitability at the gross and operating level has improved compared with earlier years, suggesting better mix, pricing, or cost control. However, net income and earnings per share have been more volatile, with a standout year in the past followed by softer results. Overall, DuPont looks steadily profitable with decent margins, but its bottom line clearly moves with economic and end‑market conditions rather than following a smooth growth path.

Balance Sheet

Balance Sheet The balance sheet appears solid and relatively stable over time. Total assets have held in a consistent range, and shareholders’ equity has remained robust, pointing to a business that is not overly reliant on borrowing. Debt has risen from earlier levels but still looks moderate relative to the company’s size and equity base. Cash balances are healthy, giving DuPont a cushion to manage downturns and support investment or restructuring as needed. In simple terms, financial leverage seems controlled, with no obvious signs of balance‑sheet strain in the data provided.

Cash Flow

Cash Flow The company consistently generates positive operating cash flow, though the amounts have swung from year to year. There was a notably weaker cash year in the middle of the period, but cash generation has since recovered to more typical levels. Free cash flow has been positive in all reported years, even after ongoing capital spending, which itself is fairly steady and not excessive. This pattern suggests DuPont can fund its reinvestment needs internally in most environments, while still leaving room for debt service, dividends, or selective strategic moves. The main risk is the inherent lumpiness of cash flows given its cyclical end markets.

Competitive Edge

Competitive Edge DuPont’s competitive position is anchored in specialty materials and solutions rather than commodity chemicals. It benefits from long‑standing brands like Kevlar, Nomex, Tyvek, and leading positions in water treatment membranes and industrial materials. Its moat is strengthened by deep technical know‑how, a large patent base, and high switching costs for customers who integrate DuPont materials into critical products and processes. Global scale and a broad industrial footprint further reinforce this position. The trade‑off is that DuPont is still exposed to industrial cycles and input‑cost swings, but it competes more on performance and innovation than on price alone, which generally supports better margins.

Innovation and R&D

Innovation and R&D Innovation is one of DuPont’s core strengths. Historically, it has repeatedly created new material categories, and that legacy continues in areas such as water purification, healthcare materials, safety products, and advanced industrial solutions. A meaningful share of revenue comes from relatively new products, indicating that research spending is translating into commercial offerings rather than sitting on the shelf. The company is also leaning into sustainability, with a large portion of its R&D directed at cleaner, more efficient, and bio‑based solutions. After spinning off its electronics business, DuPont’s innovation focus is now more concentrated on water, healthcare, construction, and transportation applications, which should make its R&D agenda clearer and more targeted.

Summary

Overall, DuPont looks like a mature, innovation‑driven industrial company with steady but cyclical revenues, improving operating profitability, and a generally healthy balance sheet and cash‑flow profile. Its long history of materials science leadership, strong brands, and patent protection provide a solid competitive base, while ongoing R&D and sustainability initiatives point toward continued evolution of its portfolio. Risks mainly center on earnings and cash‑flow volatility tied to economic cycles and customer capital spending, along with execution risk as it reshapes its business following portfolio changes. The company appears positioned as a stable, R&D‑intensive player in essential industries such as water, healthcare, and safety, rather than a high‑growth but more speculative story.